Cancer clinical trials in the region Auvergne-Rhône-Alpes

491 currently recruiting clinical trials
Region Auvergne-Rhône-Alpes

Phase 1 / Phase 2 Prostate cancer #NCT04104776 #2023-508002-20-00
Metastatic Castration-resistant 1 2 3 or more Chemotherapy Hormone therapy
Systemic Treatment-Naive
7 recruiting sites
Constellation Pharmaceutique
Phase 1 / Phase 2 Endometrial cancer #NCT04104776 #2023-508002-20-00
Endometrioid adenocarcinoma Serous adenocarcinoma Clear cell carcinoma Dedifferentiated and undifferentiated endometrial ... Locally Advanced Metastatic 1 2 Immunotherapy Chemotherapy
ARID1A Systemic Treatment-Naive
7 recruiting sites
Constellation Pharmaceutique
Phase 1 / Phase 2 Prostate cancer #NCT04104776 #2023-508002-20-00
Metastatic Hormone-sensitive Metastatic Castration-resistant 1 2 3 or more Chemotherapy Hormone therapy
Systemic Treatment-Naive
7 recruiting sites
Constellation Pharmaceutique
Phase 1 / Phase 2 Lung cancer #NCT04104776 #2023-508002-20-00
Mesothelium Locally Advanced Metastatic Other mutation 1 2 3 or more
Systemic Treatment-Naive
7 recruiting sites
Constellation Pharmaceutique
Phase 1 / Phase 2 Lymphoma #NCT04104776 #2023-508002-20-00
B cell lymphoma Large B cell lymphoma None 2 3 or more
Systemic Treatment-Naive Allogeneic stem cell transplant
7 recruiting sites
Constellation Pharmaceutique
Phase 1 / Phase 2 Endometrial cancer #NCT04104776 #2023-508002-20-00
Endometrioid adenocarcinoma Serous adenocarcinoma Clear cell carcinoma Dedifferentiated and undifferentiated endometrial ... Locally Advanced Metastatic ARID1A 1 2 3 or more
Systemic Treatment-Naive
7 recruiting sites
Constellation Pharmaceutique
Phase 1 / Phase 2 Lymphoma #NCT04104776 #2023-508002-20-00
T cell lymphoma Peripheral T cell lymphoma None 1 2 3 or more
Systemic Treatment-Naive Allogeneic stem cell transplant
7 recruiting sites
Constellation Pharmaceutique
Phase 1 / Phase 2 Kidney cancer #NCT05706129 #2023-504254-35-00
Clear cell carcinoma Locally Advanced Metastatic 2 3 or more Targeted therapy Immunotherapy Targeted therapy
8 recruiting sites
Debiopharm International SA
Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT05706129 #2023-504254-35-00
Locally Advanced Metastatic 1 2 3 or more Chemotherapy Targeted therapy
8 recruiting sites
Debiopharm International SA
Phase 1 / Phase 2 Pancreas cancer #NCT05706129 #2023-504254-35-00
Adenocarcinoma Locally Advanced Metastatic 1 2 3 or more Chemotherapy
8 recruiting sites
Debiopharm International SA